Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab

PURPOSE: To compare using immuno-PET/CT the distribution of (89)Zr-labelled rituximab without and with a preload of unlabelled rituximab to assess the impact of preloading with unlabelled rituximab on tumour targeting and radiation dose of subsequent radioimmunotherapy with (90)Y-labelled rituximab...

Descripción completa

Detalles Bibliográficos
Autores principales: Muylle, Kristoff, Flamen, Patrick, Vugts, Danielle J., Guiot, Thomas, Ghanem, Ghanem, Meuleman, Nathalie, Bourgeois, Pierre, Vanderlinden, Bruno, van Dongen, Guus A. M. S., Everaert, Hendrik, Vaes, Mélanie, Bron, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480335/
https://www.ncbi.nlm.nih.gov/pubmed/25792453
http://dx.doi.org/10.1007/s00259-015-3025-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480335/
https://www.ncbi.nlm.nih.gov/pubmed/25792453
http://dx.doi.org/10.1007/s00259-015-3025-6

Ejemplares similares